Qiagen NV (NASDAQ: QGEN ) solutions are used every day by healthcare providers to analyze patient DNA and RNA in order to guide treatment and by researchers pursuing next generation medicine. The opportunity for Qiagen to help the industry deliver the right drug to the right patient at the right dose at the right time is big, but a significant drop-off in revenue from a legacy product meant that potential didn’t translate into significant sales growth last year.
{iframe}http://www.fool.com/investing/general/2015/01/29/qiagen-nv-looks-to-the-future.aspx{/iframe}